Odunsi, a gynecologic oncologist who specializes in the treatment of ovarian cancer, serves as the Director of the Comprehensive Cancer Center and is Dean for Oncology in the BSD.
The American Institute for Medical and Biological Engineering (AIMBE) inducted Eugene B. Chang, Martin Boyer Distinguished Professor of Medicine, to its College of Fellows. Election to the AIMBE College of Fellows is among the highest professional distinctions accorded to medical and biological engineers. Chang was elected “for pioneering microbiome discoveries transforming understanding of host-microbe interactions and therapeutics in human health and disease.”
Pavitra Muralidhar, Assistant Professor of Ecology and Evolution, was one of three recipients of the Rosalind Franklin Young Investigator Award from the Genetics Society of America and The Gruber Foundation. The award is granted once every three years to women who have conducted exceptionally original and creative research in the field of genetics and have recently begun an independent faculty-level position.
Health Services Research selected an article by Betsy Cliff, Asst. Prof. Public Health Sciences, as this year's James F. Burgess Methods Article of the Year. The journal gives this award in honor of a former HSR senior associate editor to recognize excellent research in health services methods. Cliff’s paper was about creating a reliable health insurance variable in large datasets.
Nominations for the 2025 BSD Clinical Research Awards are now open! Any faculty or staff person in the BSD or UCM may nominate staff and faculty for the awards. Nominations will close on May 2 and winners will be announced during Clinical Trials Day celebrations on May 21.
Issam Awad and colleagues from the Department of Neurological Surgery assessed the safety and efficacy of atorvastatin on rebleeding in patients with cerebral cavernous malformations (CCMs) after a symptomatic hemorrhage. They found that for people with symptomatic hemorrhage caused by CCMs, atorvastatin did not affect the mean change in lesional iron deposition on brain MRI over 2 years when compared with placebo. The trial was conceived and executed at UChicago, based on preclinical bench research and biomarker validations led by the team over more than a decade.
